Paul Lab

Our focus is upon the improvement of the therapeutic and diagnostic possibilities for neuroimmunological diseases, especially for multiple sclerosis.

We are working on this with a translational approach; this means that we try to transfer new developments and findings from basic research directly into clinical work.

Further information on our website

Here you can find the press release concerning our latest results.

March 01, 2019 in Semin Immunopathol

Sex differences in autoimmune disorders of the central nervous system

S.M. Gold et al.

February 05, 2019 in Dev Med Child Neurol

The use of magnetic resonance imaging in the diagnosis of paediatric transverse myelitis

F. Paul

February 01, 2019 in Lancet Neurol

Spinal cord involvement in multiple sclerosis and neuromyelitis optica spectrum disorders

O. Ciccarelli et al.

February 01, 2019 in Mult Scler Relat Disord

Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions

M.A. Mealy et al.

February 01, 2019 in J Neurol

Can we predict cognitive decline after initial diagnosis of multiple sclerosis? Results from the German National early MS cohort (KKNMS)

A. Johnen et al.

January 21, 2019 in Front Aging Neurosci

Less is more - estimation of the number of strides required to assess gait variability in spatially confined settings

D. Kroneberg et al.

January 15, 2019 in Nat Commun

Chi3l3 induces oligodendrogenesis in an experimental model of autoimmune neuroinflammation

S.C. Starossom et al.

January 02, 2019 in Expert Rev Neurother

Novel uses of retinal imaging with optical coherence tomography in multiple sclerosis

F.C. Oertel et al.

January 01, 2019 in Neurol Neuroimmunol Neuroinflamm

N2 year in review and message from the editor to our reviewers

J. Dalmau et al.